AtriCure holds the No. 7 rank among its peers in the Medical-Systems/Equipment industry group. Brainsway ADR BWAY, iRadimed ...

Amkor Technology AMKR saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 69 ...

Discover Protagonist Therapeutics’ latest breakthroughs in hematology and immunology drugs, market opportunities, and R&D insights from the 2025 ...

Detailed price information for Spyre Therapeutics Inc (SYRE-Q) from The Globe and Mail including charting and trades.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Stifel initiated coverage of TAT Technologies and resumed coverage of VSE Corp with Buy ratings, saying both companies are well placed to benefit from what it called a “stronger for longer” upcycle in ...

AbbVie surges 22.5% YTD as new drugs Skyrizi and Rinvoq drive growth, offsetting Humira losses and fueling long-term momentum.

I agree to the Terms of Use , Privacy Notice and Cookie Notice. I would like to receive updates and special offers from Dow ...

Continue reading this article with a Barron’s subscription ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of Ryoncil ® (remestemcel-L-rknd), ...